Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) Return on Capital Employed (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 7 years of Return on Capital Employed data on record, last reported at 0.4% in Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 27.0% year-over-year to 0.4%; the TTM value through Sep 2025 reached 0.4%, up 27.0%, while the annual FY2024 figure was 0.34%, 61.0% up from the prior year.
  • Return on Capital Employed reached 0.4% in Q3 2025 per CYCN's latest filing, up from 0.43% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.47% in Q2 2023 and bottomed at 2.1% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 0.86%, with a median of 0.99% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: surged 222bps in 2023, then crashed -162bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 1.05% in 2021, then decreased by -26bps to 1.33% in 2022, then increased by 20bps to 1.06% in 2023, then soared by 60bps to 0.43% in 2024, then grew by 5bps to 0.4% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.4% in Q3 2025, 0.43% in Q2 2025, and 0.4% in Q1 2025.